CN111714392A - 具有亮丽肌肤功效的化妆品精华液及其制备方法 - Google Patents
具有亮丽肌肤功效的化妆品精华液及其制备方法 Download PDFInfo
- Publication number
- CN111714392A CN111714392A CN202010526039.2A CN202010526039A CN111714392A CN 111714392 A CN111714392 A CN 111714392A CN 202010526039 A CN202010526039 A CN 202010526039A CN 111714392 A CN111714392 A CN 111714392A
- Authority
- CN
- China
- Prior art keywords
- parts
- phase
- extract
- essence
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 51
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 238000005282 brightening Methods 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 40
- 239000000284 extract Substances 0.000 claims abstract description 27
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004359 castor oil Substances 0.000 claims abstract description 21
- 235000019438 castor oil Nutrition 0.000 claims abstract description 21
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 21
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 21
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 20
- 229940069521 aloe extract Drugs 0.000 claims abstract description 20
- 229960000271 arbutin Drugs 0.000 claims abstract description 20
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 20
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 20
- 241000628997 Flos Species 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims description 22
- 241000220317 Rosa Species 0.000 claims description 15
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims description 13
- 235000019719 rose oil Nutrition 0.000 claims description 13
- 239000010666 rose oil Substances 0.000 claims description 13
- 229940076591 saffron extract Drugs 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 210000003491 skin Anatomy 0.000 abstract description 43
- 239000000686 essence Substances 0.000 abstract description 38
- 239000003921 oil Substances 0.000 abstract description 6
- 241001116389 Aloe Species 0.000 abstract description 5
- 235000011399 aloe vera Nutrition 0.000 abstract description 5
- 239000011148 porous material Substances 0.000 abstract description 5
- 230000028327 secretion Effects 0.000 abstract description 5
- 208000020154 Acnes Diseases 0.000 abstract description 4
- 238000004140 cleaning Methods 0.000 abstract description 4
- 239000004519 grease Substances 0.000 abstract description 4
- 210000003780 hair follicle Anatomy 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000000474 nursing effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 235000015655 Crocus sativus Nutrition 0.000 abstract description 3
- 244000124209 Crocus sativus Species 0.000 abstract description 3
- 229940060184 oil ingredients Drugs 0.000 abstract description 3
- 235000013974 saffron Nutrition 0.000 abstract description 3
- 239000004248 saffron Substances 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Abstract
本发明公开了一种具有亮丽肌肤功效的化妆品精华液及其制备方法，涉及化妆品领域，该具有亮丽肌肤功效的化妆品精华液的配方成分包括：水、丁二醇、藏红花提取物、芦荟提取物、玫瑰花提取物、玫瑰花油、熊果苷、凝血酸、透明质酸钠PEG‑40、氢化蓖麻油、苯氧乙醇。该具有亮丽肌肤功效的化妆品精华液采用藏红花和芦荟等本草精华为原料制造，进行毛囊清洁疏通、收敛毛孔、抑制多余油脂分泌和护理，起到预防和治疗痘痘的作用。
Description
技术领域
本发明涉及化妆品领域，更具体地说，本发明涉及一种具有亮丽肌肤功效的化妆品精华液及其制备方法。
背景技术
精华液是用于脸部的护肤品中的一种，精华液含有较珍贵的功效成分，如植物提取物、神经酰胺、角鲨烷等，精华液的作用有防衰老、抗皱、保湿、美白、去斑等等。精华液通常使用在护肤水之后，乳液或面霜之前。由于精华液中富含多种功效成分且浓度较高。现有的护肤化妆用精华液采样的原料比较普通，对毛囊清洁疏通、收敛毛孔、抑制多余油脂分泌和护理方面的效果一般，对于祛痘、毛孔、亮肤、紧致、改善皮肤的综合效果不佳。
发明内容
本发明所要解决的问题是提供一种具有亮丽肌肤功效的化妆品精华液及其制备方法，采用藏红花和芦荟等本草精华为原料制造，进行毛囊清洁疏通、收敛毛孔、抑制多余油脂分泌和护理，起到预防和治疗痘痘的作用。
为了实现上述目的，本发明采取的技术方案为：
该具有亮丽肌肤功效的化妆品精华液的配方成分包括：70～80份水、5～9份丁二醇、10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇，所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将5～9份丁二醇、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇加入70～80份水混匀，得到A相；
(2)再将10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
优选的，所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将9份丁二醇、9份熊果苷、9份凝血酸、5份透明质酸钠PEG-40、15份氢化蓖麻油、9份苯氧乙醇加入70份水混匀，得到A相；
(2)再将10份藏红花提取物、10份芦荟提取物、15份玫瑰花提取物、10份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
优选的，所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将7份丁二醇、7份熊果苷、7份凝血酸、3份透明质酸钠PEG-40、13份氢化蓖麻油、7份苯氧乙醇加入75份水混匀，得到A相；
(2)再将13份藏红花提取物、13份芦荟提取物、13份玫瑰花提取物、8份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
优选的，所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将5份丁二醇、5份熊果苷、5份凝血酸、2份透明质酸钠PEG-40、10份氢化蓖麻油、5份苯氧乙醇加入80份水混匀，得到A相；
(2)再将15份藏红花提取物、15份芦荟提取物、10份玫瑰花提取物、5份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
有益效果：该具有亮丽肌肤功效的化妆品精华液采用水、丁二醇、藏红花提取物、芦荟提取物、玫瑰花提取物、玫瑰花油、熊果苷、凝血酸、透明质酸钠PEG-40、氢化蓖麻油、苯氧乙醇为原料制造而成。芦荟微苦凉性清热解毒，红花微苦温性活血化瘀，其具有美容养颜的功效。该具有亮丽肌肤功效的化妆品精华液采用藏红花和芦荟等本草精华为原料制造，进行毛囊清洁疏通、收敛毛孔、抑制多余油脂分泌和护理，起到预防和治疗痘痘的作用。
具体实施方式
实施例1：
该具有亮丽肌肤功效的化妆品精华液的配方成分包括：70～80份水、5～9份丁二醇、10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇。
该具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将9份丁二醇、9份熊果苷、9份凝血酸、5份透明质酸钠PEG-40、15份氢化蓖麻油、9份苯氧乙醇加入70份水混匀，得到A相；
(2)再将10份藏红花提取物、10份芦荟提取物、15份玫瑰花提取物、10份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
实施例2：
该具有亮丽肌肤功效的化妆品精华液的配方成分包括：70～80份水、5～9份丁二醇、10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇。
该具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将7份丁二醇、7份熊果苷、7份凝血酸、3份透明质酸钠PEG-40、13份氢化蓖麻油、7份苯氧乙醇加入75份水混匀，得到A相；
(2)再将13份藏红花提取物、13份芦荟提取物、13份玫瑰花提取物、8份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
实施例3：
该具有亮丽肌肤功效的化妆品精华液的配方成分包括：70～80份水、5～9份丁二醇、10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇。
该具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将5份丁二醇、5份熊果苷、5份凝血酸、2份透明质酸钠PEG-40、10份氢化蓖麻油、5份苯氧乙醇加入80份水混匀，得到A相；
(2)再将15份藏红花提取物、15份芦荟提取物、10份玫瑰花提取物、5份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
该具有亮丽肌肤功效的化妆品精华液采用水、丁二醇、藏红花提取物、芦荟提取物、玫瑰花提取物、玫瑰花油、熊果苷、凝血酸、透明质酸钠PEG-40、氢化蓖麻油、苯氧乙醇为原料制造而成。芦荟微苦凉性清热解毒，红花微苦温性活血化瘀，其具有美容养颜的功效。丁二醇在化妆品中有保湿的作用，它的质地非常温和，是一种清爽不粘腻的溶液，经常被添加在护肤品中。丁二醇成分非常安全，不会对肌肤产生一些不良影响，丁二醇还有破坏细菌生存环境的作用，长时间使用，可以抑制细菌增长。丁二醇保湿护肤的原理是将护肤品中的水分停留在角质层，在肌肤表面形成一层薄膜。藏红花提取物含红花甙，红花黄色素。另含脂肪油，称红花油，是棕榈酸，硬脂酸花生酸，亚油酸，亚麻酸，油酸等等油脂类。藏红花提取物具有美容、养颜、祛斑等功效，可以活血化瘀、补血、养血、理血、行血，能养能导起到双向调节的作用。芦荟提取物可以有效的激活皮肤的细胞，然后对皮肤有滋养，温和的作用，促进细胞再生有着很强的生理作用，对组织的受损部位，有强大的自下而上的新生细胞堆积修复能力。玫瑰花提取物和玫瑰花油具有抗氧化抗自由基功效，强化防御功能，可加速血液循环，有助于干性皮肤皮脂腺分泌。玫瑰萃取物，可以有效改善肌肤粗糙，恢复肌肤的柔软及紧致，让表皮纹理更细腻。玫瑰萃取液本身具有保湿剂美白的效果。有效补充水分，内含的保湿因子，能被皮肤充分吸收并保存水分，达到保湿的功效。熊果苷能够通过抑制体内酪氨酸酶的活性，阻止黑色素的生成，从而减少皮肤色素沉积，祛除色斑和雀斑，同时还有杀菌、消炎的作用。凝血酸能够起到快速美白、淡化斑点和防止黑色素聚集的作用，它使得皮肤呈现出白皙柔润、明亮晶透的肤质。凝血酸比起传统的美白成分效果稳定，受高温制作限制，不用各类载体的保护传递效果也能达到美白的效果。透明质酸钠PEG-40对皮肤具有保湿作用、营养作用、皮肤损伤修复和预防、润滑性和成膜性、增稠性还有抗皱性。氢化蓖麻油是化妆品中一种常见的溶剂。氢化蓖麻油可以将香精、精油里面的油性物质均匀的分散到水中，形成稳定、透明的溶液，可以当做皮肤清洁剂使用，并且还有治疗粉刺和延缓衰老迹象等功效。苯氧乙醇是一种经常用于护肤产品的有机化合物，可由乙二醇及苯酚醚化而成。
该具有亮丽肌肤功效的化妆品精华液采用藏红花和芦荟等本草精华为原料制造，进行毛囊清洁疏通、收敛毛孔、抑制多余油脂分泌和护理，起到预防和治疗痘痘的作用。
以上所述仅为本发明的实施例，并非因此限制本发明的专利范围，凡是利用本发明说明书及实施方式内容所作的等效结构或等效流程变换，或直接或间接运用在其他相关的技术领域，均同理包括在本发明的专利保护范围内。
Claims (4)
1.一种具有亮丽肌肤功效的化妆品精华液及其制备方法，其特征在于，所述具有亮丽肌肤功效的化妆品精华液的配方成分包括：70～80份水、5～9份丁二醇、10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇，所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将5～9份丁二醇、5～9份熊果苷、5～9份凝血酸、2～5份透明质酸钠PEG-40、10～15份氢化蓖麻油、5～9份苯氧乙醇加入70～80份水混匀，得到A相；
(2)再将10～15份藏红花提取物、10～15份芦荟提取物、10～15份玫瑰花提取物、5～10份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
2.按照权利要求1所述的一种具有亮丽肌肤功效的化妆品精华液及其制备方法，其特征在于：所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将9份丁二醇、9份熊果苷、9份凝血酸、5份透明质酸钠PEG-40、15份氢化蓖麻油、9份苯氧乙醇加入70份水混匀，得到A相；
(2)再将10份藏红花提取物、10份芦荟提取物、15份玫瑰花提取物、10份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
3.按照权利要求1所述的一种具有亮丽肌肤功效的化妆品精华液及其制备方法，其特征在于：所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将7份丁二醇、7份熊果苷、7份凝血酸、3份透明质酸钠PEG-40、13份氢化蓖麻油、7份苯氧乙醇加入75份水混匀，得到A相；
(2)再将13份藏红花提取物、13份芦荟提取物、13份玫瑰花提取物、8份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
4.按照权利要求1所述的一种具有亮丽肌肤功效的化妆品精华液及其制备方法，其特征在于：所述具有亮丽肌肤功效的化妆品精华液的制备方法包括如下步骤：
(1)将5份丁二醇、5份熊果苷、5份凝血酸、2份透明质酸钠PEG-40、10份氢化蓖麻油、5份苯氧乙醇加入80份水混匀，得到A相；
(2)再将15份藏红花提取物、15份芦荟提取物、10份玫瑰花提取物、5份玫瑰花油加入A相中混匀得到B相；
(3)将所述B相过滤后保留滤液，即得精华液。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010526039.2A CN111714392A (zh) | 2020-06-05 | 2020-06-05 | 具有亮丽肌肤功效的化妆品精华液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010526039.2A CN111714392A (zh) | 2020-06-05 | 2020-06-05 | 具有亮丽肌肤功效的化妆品精华液及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111714392A true CN111714392A (zh) | 2020-09-29 |
Family
ID=72567921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010526039.2A Pending CN111714392A (zh) | 2020-06-05 | 2020-06-05 | 具有亮丽肌肤功效的化妆品精华液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111714392A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115670990A (zh) * | 2021-12-29 | 2023-02-03 | 上海优萃生物科技有限公司 | 一种美白组合物及制备方法和应用 |
-
2020
- 2020-06-05 CN CN202010526039.2A patent/CN111714392A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115670990A (zh) * | 2021-12-29 | 2023-02-03 | 上海优萃生物科技有限公司 | 一种美白组合物及制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102165385B1 (ko) | 피부 노화 및 주름의 치료 및 예방을 위한 감마-디케톤 | |
| CN107334726B (zh) | 一种祛痘组合物及其制备方法和应用 | |
| CN104856892A (zh) | 一种富含生长因子的化妆品或护肤品制剂及其制备方法 | |
| CN110638707A (zh) | 一种眼部护理霜及其制备方法 | |
| CN112870116B (zh) | 滋润保湿修复嘴唇的润唇膏及其制备方法、滋润保湿修复嘴唇的口红及其制备方法 | |
| CN106265471A (zh) | 一种含芦荟的补水保湿化妆品组合物及其应用 | |
| CN110960458A (zh) | 一种保湿精华乳液及其制备方法 | |
| CN111514036A (zh) | 一种提拉紧致抗衰老面膜及其制备方法 | |
| KR20220114509A (ko) | 세정제 조성물 및 그에 의해 제조된 올인원 세정제 | |
| CN111973486A (zh) | 一种神经酰胺滋润保湿霜及其制备方法 | |
| CN110559226A (zh) | 一种美白液及其制备方法 | |
| CN111789804A (zh) | 一种美白保湿乳液及其制备方法 | |
| CN107213062B (zh) | 一种皙透亮白洁面乳及其制备方法 | |
| CN111714392A (zh) | 具有亮丽肌肤功效的化妆品精华液及其制备方法 | |
| CN113133967A (zh) | 一种牡丹精华液润肤面乳及其制备方法 | |
| CN106333880B (zh) | 一种稀薄乳液基质的爽肤水及其制备方法 | |
| CN110917052A (zh) | 一种含有椰子油的保湿面膜液及其制备方法、贴片面膜 | |
| CN111743826A (zh) | 一种祛斑抗皱保湿乳液 | |
| JP6807636B2 (ja) | 外用組成物 | |
| KR20090105222A (ko) | 모공 축소용 화장료 조성물 | |
| CN114010551A (zh) | 补水保湿组合物及其应用、化妆水 | |
| CN113116753A (zh) | 一种玫瑰精油面霜及其制备方法 | |
| CN113069377A (zh) | 一种抗衰老面霜及其制备方法 | |
| KR101436819B1 (ko) | 피부 보습, 진정 및 여드름 개선용 화장료 조성물 | |
| CN112137927A (zh) | 高渗透、重现光感初生肌的纤连蛋白精华乳及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200929 |
|
| WD01 | Invention patent application deemed withdrawn after publication |